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Loss of dopaminergic (DA) neurons leads to Parkinson’s disease; however, themechanism(s) for the vulnerability of DA neurons is(are)
not fully understood.Wedemonstrate that TRPC1 regulates the L-typeCa2 channel that contributes to the rhythmic activity of adult DA
neurons in the substantia nigra region. Store depletion that activates TRPC1, via STIM1, inhibits the frequency and amplitude of the
rhythmic activity in DA neurons of wild-type, but not in TRPC1/, mice. Similarly, TRPC1/ substantia nigra neurons showed
increased L-type Ca2 currents, decreased stimulation-dependent STIM1-Cav1.3 interaction, and decreased DA neurons. L-type Ca
2
currents and the open channel probability of Cav1.3 channels were also reduced upon TRPC1 activation, whereas increased Cav1.3
currents were observed upon STIM1 or TRPC1 silencing. Increased interaction between Cav1.3-TRPC1-STIM1 was observed upon store
depletion and the loss of either TRPC1 or STIM1 led to DA cell death, which was prevented by inhibiting L-type Ca2 channels. Neuro-
toxins that mimic Parkinson’s disease increased Cav1.3 function, decreased TRPC1 expression, inhibited Tg-mediated STIM1-Cav1.3
interaction, and induced caspase activation. Importantly, restoration of TRPC1 expression not only inhibited Cav1.3 function but in-
creased cell survival. Together, we provide evidence that TRPC1 suppresses Cav1.3 activity by providing an STIM1-based scaffold, which
is essential for DA neuron survival.
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Introduction
Parkinson’s disease (PD) is a progressive, hypokinetic, neurode-
generative disease. Although the cause of PD is not well under-
stood, it is known that the loss of dopaminergic (DA) neurons in
the substantia nigra (SN) region underlies themainmotor symp-
toms for this disease but themechanism is still not clear. In recent
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Significance Statement
Ca2 entry serves critical cellular functions in virtually every cell type, and appropriate regulation of Ca2 in neurons is essential
for proper function. In Parkinson’s disease, DA neurons are specifically degenerated, but the mechanism is not known. Unlike
otherneurons,DAneuronsdependonCav1.3 channels for their rhythmic activity.Our studies show that, innormal conditions, the
pacemaking activity inDAneurons is inhibited by the TRPC1-STIM1 complex. Neurotoxins thatmimic Parkinson’s disease target
TRPC1 expression, which leads to an abnormal increase in Cav1.3 activity, thereby causing degeneration of DA neurons. These
findings link TRPC1 to Cav1.3 regulation and provide important indications about how disrupting Ca
2 balance could have a
direct implication in the treatment of Parkinson’s patients.
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years, attention has turned to the role of calcium (Ca2) in the
onset of PD. Ca2-induced excitotoxicity has been considered an
important mechanism leading to DA neuron cell death. How-
ever, not all of the DA midbrain neurons are equally affected by
the degenerative process in PD. In particular, SNDA neurons are
highly vulnerable to being affected via environmental factors and
toxins that lead to PD compared withmore resistant neighboring
VTA DA neurons (Bjo¨rklund and Dunnett, 2007; Dragicevic et
al., 2015). It has been proposed that sodium channels play a ma-
jor role in the spike generation of VTA DA cells, whereas Ca2
channels could contribute to the pacemaking activity in SN DA
neurons.
L-type Ca2 channels, mainly Cav1.3, have been shown to
contribute to the rhythmic activity of DA neurons in the SN
region and could render DA neurons susceptible to mitochon-
drial toxins (Guzman et al., 2010; Surmeier et al., 2011;
Dryanovski et al., 2013). Importantly, an increase in Cav1.3 ex-
pression was observed in PD brains, which precedes PD pathol-
ogy (Hurley et al., 2015). In addition, a change in the ratio of
CaV1.2 versus CaV1.3 was observed that could contribute to
Ca2-mediated excitotoxicity (Guzman et al., 2010; Kang et al.,
2012; Hurley et al., 2015). Consistent with these studies, patients
treated with Cav1 antagonists had a decreased risk for PD (Ritz et
al., 2010; Marras et al., 2012). However, in PD, not all DA neu-
rons degenerate andmost neurons start to degenerate at the later
stage of life, suggesting that there could be alternative mecha-
nisms that may inhibit Cav1.3 activity and help in the survival of
DA neurons.
Changes in Ca2 homeostasis with regard to storage organ-
elles, such as the ER and mitochondria, have also been shown to
affect neuronal survival and are closely linked with PD (Kazuno
et al., 2006). Ca2 entry through the store-operated Ca2 entry
(SOCE) channels is essential for maintaining intracellular Ca2
stores thus could regulate neuronal function and survival (Bol-
limuntha et al., 2006; Selvaraj et al., 2012). TRPC1 has been sug-
gested as a candidate for SOCE-mediated Ca2 entry and has
been shown to be critical for neuronal survival (Wang and Poo,
2005; Bollimuntha et al., 2006; Selvaraj et al., 2012). In addition,
stromal interacting molecule-1 (STIM1) has been identified as
the primary regulator of SOCE-mediated Ca2 entry, and store
depletion allows STIM1 rearrangement followed by its interac-
tion with TRPC1 that induces Ca2 entry (Huang et al., 2006;
Pani et al., 2012). Interestingly, STIM1 has also been shown to
inhibit L-type Ca2 channels (Park et al., 2010; Wang et al.,
2010); however, the mechanism as to how STIM1 inhibits L-type
Ca2 channels is not known. Furthermore, a role for SOCE-
mediated Ca2 entry in the regulation of Cav1.3 channels in DA
neurons has yet to be established. Thus, the objective of this study
was to identify the relationship betweenTRPC1 andCav1.3 chan-
nels and establish their role in regulating DA neuronal function.
Our previous studies have shown that TRPC1 channels are im-
portant for DA neuronal function and protect against cytotoxic-
ity induced by neurotoxins by inhibiting ER stress (Selvaraj et al.,
2009, 2012). Results presented here indicate, for the first time,
that TRPC1 is essential for the inhibition of L-type Ca2 chan-
nels. DA neurons in TRPC1/ mice showed increased sponta-
neous rhythmic activity as well as increased degeneration of DA
neurons. Furthermore, the frequency of neuronal firing was in-
creased in DA neurons of TRPC1/mice and TRPC1-inhibited
L-type Ca2 channel, especially Cav1.3 activity, by facilitating an
STIM1-Cav1.3 interaction, which was essential for the protection
of DA neurons.
Materials andMethods
Cell culture, transfections, and viability assays. SH-SY5Y cells were ob-
tained from the ATCC and cultured/maintained at 37°C with 95% hu-
midified air and 5% CO2 and differentiated as previously described
(Bollimuntha et al., 2005; Selvaraj et al., 2012). For transient transfection,
SH-SY5Y cells were transfected with TRPC1siRNA (Ambion) or Cav1.3
siRNA or STIM1siRNA or scrambled control siRNA (Ambion negative
control siRNA #1) using HiPerfect transfection reagent (QIAGEN). For
rescue experiments, cells were transfectedwith siSTIM1 for 24 h followed
by overexpression of full-length STIM1 (10-fold concentration). For vi-
ability assays, cells were seeded in 96-well plates at a density of 0.5 105
cells/well. The cultures were grown for 24 h under different conditions,
and cell viability was measured by using the MTT method as described
previously (Selvaraj et al., 2012).
Animals and human brain samples. Two- to 5-week-old male C57BL/6
(Charles River) or TRPC1/mice were used for these experiments. The
TRPC1/micewere generated as previously described (Liu et al., 2007).
All animals were housed in a temperature-controlled room under a
12/12 h light/dark cycle with ad libitum access to food and water, and
experiments were performed as per the institutional guidelines for the
use and care of animals. Frozen and paraffin-embedded blocks of post-
mortem human SN samples of control (6 samples, males with age rang-
ing from 65 to 72 years) and PD patients (8 samples, males and females
with age ranging from 60 to 72 years, with severe motor neuron deficit)
were obtained from United Kingdom Parkinson’s foundation as well as
Udall Parkinson Center (Philadelphia). All human subjects were ap-
proved by the institutional review board. Immunofluorescence was per-
formed on sections using specific antibodies as described.
Brain slice preparation and electrophysiology. Mice (2–5 weeks old)
were killed, and the brain was dissected in ice-cold saline solution. Cor-
onal brain sections (400m)were cut using a vibrating blademicrotome
(VT1000S; Leica). Brain slice recordings were performed under infrared
videomicroscopy (Olympus BX51WI) as described previously (Zhang et
al., 2014). Recording electrodes were filled with (in mM) as follows: 100
K-gluconate, 0.6 EGTA, 2 MgCl2, 8 NaCl, 33 HEPES, 2 ATPNa2, 0.4
GTPNa, and 7 phosphocreatine, pH 7.4. The extracellular solution com-
prised the following (in mM): 130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25
NaH2PO4, 2.5 CaCl2, 1.5 MgCl2, and 10 glucose, saturated with 95% O2
and 5%CO2, pH7.4. For calciumcurrent recordings, TTX is added in the
extracellular solution and K-gluconate is replaced with CsCL in intra-
cellular solution. For SOCE current recordings, recording electrodes
were filled with the following (in mM): 110 CsCl, 5 MgCl2, 10 EGTA, 10
HEPES, 4 ATPNa2, and 0.1 GTPNa, pH 7.4. Treatments applied after the
firing had been stable for 5–10 min. Amplitude and frequency were cal-
culated by Mini Analysis 6.0.1 (Synaptosoft). For Ca2 currents, cells
were voltage-clamped using a train of three action potentials (APs) that
showed spontaneous firing and was used to establish the time course of
Ca2 currents under AP trains (Marcantoni et al., 2010; Vandael et al.,
2012). For single-cell recordings, coverslips with SH-SY5Y cells were
transferred to the recording chamber and perfused with an external
Ringer’s solution of the following composition (mM): 125 TEA-Cl, 10
CaCl2, 10 HEPES, 10 glucose, pH 7.4 (Tris). The patch pipette was filled
with the standard intracellular solution that contained the following
(mM): 130 CsCL, 2 MgCl2, 20 HEPES, 11 EGTA, 2 Na2ATP, 0.1 GTP, 10
glucose, pH 7.3 (CsOH). All electrophysiological experiments were fil-
tered at 2 kHz, digitized at 10 kHz, and acquired and analyzed using
pCLAMP 10 software (Molecular Devices). All experiments were per-
formed at room temperature.
Single-channel recording. For single-channel recording in cell-attached
configuration, recording electrodes were filled with the following (in
mM): 100 TEA-Cl, 10 BaCl2, 10 HEPES, pH 7.4 (Tris). The extracellular
solution used to set the membrane potential to zero comprised of the
following (in mM): 104 K-aspartate, 1 MgCl2, 10 HEPES, 10 EGTA, pH
7.4.Datawere obtained in response tomembrane depolarizing pulse, 200
ms duration, from an intracellular holding 40 mV, filtered at 2 kHz,
digitized at 10 kHz, and acquired and analyzed using pCLAMP10 soft-
ware (Molecular Devices). A threshold level was set at one-half of the
estimated unitary current amplitude. The low-variance analysis was used
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to estimate single-channel current levels. Briefly, the mean current am-
plitude and variance were calculated for a window advanced across the
record in 1 point increments. If the variance in thewindowwas below the
baseline variance, the mean current amplitude was kept for the histo-
gram. The histogram bin width was 0.05 pA for all experiments. All
experiments were performed at room temperature.
Calcium measurement. Cells were incubated with 2 M fura-2 (Invit-
rogen) for 45 min and washed twice with Ca2 free standard external
solution, including the following: 10 mM HEPES, 120 mM NaCl, 5.4 mM
KCl, 1 mM MgCl2, 10 mM glucose, pH 7.4, buffer. For fluorescence mea-
surements, the fluorescence intensity of fura-2-loaded control cells was
monitored with a CCD camera-based imaging system (Compix). A
monochromator dual-wavelength enabled alternative excitation at 340
and 380 nm, whereas the emission fluorescence was monitored at 510
nm. The images of multiple cells collected at each excitation wavelength
were processed using the C imaging, PCI software (Compix), to provide
ratios of fura-2 fluorescence from excitation at 340 nm to that from
excitation at 380 nm (F340/F380).
Immunofluorescence and immunohistochemistry. Animals were anes-
thetized and fixed by perfusion with PBS followed by PFA (4%, w/v) in
PBS. The whole brain was removed and fixed again overnight in PFA
(3%), cryoprotected in 30% sucrose in PBS for 24 h at 4°C, and then
frozen in OCT freezing compound (Ted Pella). Serial cryosections were
collected through the entire midbrain (10 M) and stained using TH-
specific antibodies. Secondary antibodies that were conjugated with a
fluorophore were used to label individual protein; samples without pri-
mary antibody were used as a control. For immunohistochemistry, the
Vector ABC Elite kit (Vector Laboratories) was used along with 33
diaminobenzoic acid as a chromogen to develop the reaction in the pres-
ence of H2O2 (Selvaraj et al., 2009). All samples were examined and
images obtained using a Leica and Zeiss Meta confocal microscope. For
quantitative measurements, persons blind to the treatment counted the
number of TH-positive neurons in the SNpars compacta.Measurements
from four to six sections per brain were averaged to obtain one value per
subject.
Immunoprecipitation and Western blot analysis. Rabbit polyclonal
Ab anti-TRPC1 (catalog #ACC-010), anti-TRPC3 (catalog #ACC-
016), anti-Orai1, and anti-Cav1.3 (catalog #ACC-005) were pur-
chased from Alomone Labs. Goat polyclonal Ab against -actin
(catalog #sc-1616) was obtained from Santa Cruz Biotechnology.
Rabbit monoclonal Ab against STIM1 (catalog #4916), cleaved
caspase3 (catalog #9664), Bak (catalog #2772), and Bid (catalog
#2002) were purchased from Cell Signaling Technology. Cells or SN
tissues were stimulated (with and without Tg 2M) as indicated in the
figure followed by the addition of RIPA buffer to obtain cell lysates
from both differentiated SH-SY5Y cells and SN region of the brain.
Protein concentrations were determined using the Bradford reagent
(Bio-Rad); 25 g of lysates was resolved on NuPAGE 4%–12% Bis-
Tris gels (Invitrogen) and followed by Western blotting as described
previously (Bollimuntha et al., 2005; Selvaraj et al., 2009). For immu-
noprecipitation, 1 mg of total lysate was incubated overnight (4°C)
with the primary antibody, followed by the addition of protein A
beads for 3 h, washed with high salt buffer, and resolved on the gel.
Intrasubstantia nigral injection.Mice received a unilateral injection
of either control virus (Ad-GFP) or Ad-TRPC1 (3 10 7 particles per
construct in 3 l) into the SN. After 1 week of adenovirus injection,
mice were challenged with MPTP (MPTP-HCl 25 mg/kg per injection
for 5 consecutive days at 24 h intervals). After additional 2 weeks, the
brain was removed from the skull and placed dorsal side up. Using a
scalpel blade, a coronal cut was made adjacent to the inferior colliculi
at bregma 6.36 mm. A second cut was made at bregma 2.54
mm, based on the mouse brain atlas. The ventral midbrain was dis-
sected to ensure that there was no contamination of the hippocam-
pus, cortex, or cerebellum. Brain regions from 2 or 3 animals were
pooled for each experiment.
Statistical analysis. Data analysis was performed using Origin 9.0
(OriginLab). Student’s paired or unpaired t test or ANOVAwas used for
statistical analysis as appropriate;N indicates the cells or slices examined.
Differences in the mean values (mean  SEM) were considered to be
significant at p 0.05.
Results
L-type Ca2 channel contributes to the rhythmic activity of
DA neurons in the SN region
The loss of DA neurons in the SN region is a prominent charac-
teristic of PD. Thus, we analyzed the expression of the dopamine
transporter (DAT), which is a marker for dopaminergic neurons
in control and PD samples. Importantly, expression of DAT pro-
tein was decreased in human PD patients (Fig. 1A,B). Further-
more, most of the DAT staining in PD patients coincided with
endocytic vesicular staining, suggesting that DA neurons are af-
fected in PD. However, as both DA and GABAergic neurons are
present in the SN region that modulates dopamine release and
function, electrophysiological experiments were performed in
slices obtained from SN region of adults (p	 28 d) mice. In the
whole-cell configuration, the mean frequency of spontaneous
APs in GABAergic neurons was much higher than that observed
inDAneurons (Fig. 1C,E). Hyperpolarizing current pulses of 200
pA were also used to distinguish between the two neuronal pop-
ulations, and APs evoked by current injection showed distinct
characteristics between the DA and GABAergic neurons (Mat-
suda et al., 1987; Yung et al., 1991; Richards et al., 1997; Seutin
and Engel, 2010) (Fig. 1D,F). Additionally, consistent with pre-
vious reports (Okamoto et al., 2006), DA neurons, exhibited Ih
ratio 0.6, whereas GABAergic neurons showed a small Ih (Ih
ratio 	0.6) (Fig. 1G–I), in accordance with the presence of the
two different types of neurons in the SN region.
One of the fundamental questions that need to be addressed is
why distinctively DA neurons are vulnerable in PD. Interestingly,
most neurons exhibit exclusively TTX (a Na channel inhibitor)
sensitive autonomous pacemakers; however, in the SN area, DA
neurons have shown to be partially dependent on Ca2 for its
autonomous pacemaking activity (Surmeier et al., 2011). To
study this further, tissue slices from the adult SN area were used
and AP activity was recorded. As shown in Figure 2A, B, the
addition of TTX completely blocked the rhythmic activity in
GABAergic neurons. Similar results were also observed in juve-
nile (P14-P18 d) DA neurons (Fig. 2C,D), which showed that
TTX was also able to block the rhythmic activity in DA neurons.
In contrast, the rhythmic activity of aged DA neurons (p	 28 d)
was only partially decreased by the addition of TTX (Fig. 2E,F).
In addition, 20% of cells showed slow oscillatory potentials upon
application of TTX (Fig. 2G). Furthermore, the rhythmic activity
was facilitated by the application of Bay K8644 (L-type Ca2
channel activator) (Fig. 2H). The addition of nifedipine (an
L-type Ca2 channel blocker) along with TTX completely
abolished the rhythmic activity of aged DA neurons (Fig. 2I).
Importantly, removal of external Ca2 completely inhibited the
TTX-resistant rhythmic activity in adult DA neurons (Fig. 2J).
Together, these results suggest that the rhythmic activity in aged
DA neurons is in part driven by the L-type Ca2 channels. In
neurons, L-type Ca2 channels have one of the two 1-subunits:
Cav1.2 or Cav1.3. The Cav1.3 subunits are highly expressed in the
SN region and open at relatively hyperpolarized potentials (Ko-
schak et al., 2001; Xu and Lipscombe, 2001; Helton et al., 2005;
Chan et al., 2007; Surmeier et al., 2011; Hurley et al., 2015).
Together, these data suggest that the contribution of L-type Ca2
channels, especially Cav1.3, could play a key role in DA neuron
vulnerability and degeneration.
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TRPC1 inhibits the rhythmic activity of DA neurons in the
SN area
Our previous studies had shown that another Ca2 channel,
TRPC1, is also involved in regulating Ca2 homeostasis and pro-
tects against the loss of DA neurons (Bollimuntha et al., 2005;
Selvaraj et al., 2012). Thus, given the importance of Ca2 for the
rhythmic activity in DA neurons, we further investigated the re-
lationship between L-type Ca2 channels and TRPC1 in aged DA
neurons (p	 28 d). The spontaneous activity of DA neurons was
recorded under the current-clamp mode. Interestingly, tissue
slices from SN region of TRPC1/ mice showed an increase in
the AP (1.02  0.07 Hz, n 
 9) compared with age-matched
wild-type control mice (0.80  0.04 Hz, n 
 9) (Fig. 3A,E),
suggesting that loss of TRPC1 increases the rhythmic activity of
the DA neurons. To further confirm this, TTX was added; and
although TTX decreased the rhythmic activity of DA neurons in
wild-type mice and TRPC1/ mice, the rhythmic activity in
TRPC1/ mice (0.41  0.03 Hz, n 
 9) was slightly higher
compared with wild-type DA neurons (0.35  0.04 Hz, n 
 9)
treated with TTX (Fig. 3B,F,M). The addition of nifedipine,
which blocks L-type Ca2 channels, inhibited the pacemaking
activity in both wild-type and TRPC1/mice (data not shown).
More importantly, application of thapsigargin (Tg, a SERCA
pump blocker, which activates TRPC1 channels) (Liu et al., 2003;
Figure 1. Functional characterization of DA and GABAergic neurons in the SN region. A, Paraffin-embedded sections of postmortem human SN region obtained from control and PD patients.
Sectionswere immunostained usingDAT.B, Quantification of the fluorescence obtained from5or 6 individual sections. Patterns of AP firing using tissue slices fromSN area in a GABAneuron (C) and
in adult DAneurons (E). Traceswere recordedwithout current injection.D,F, Voltage traceswere evokedby a series of 1000ms current pulses (from200pAwith increment40pA).G,H, Current
traces evoked by50 mV steps from holding potential60 mV. I, Bar graph represents Ih ratio in GABA and DA neurons (n
 15). *p 0.05.
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Selvaraj et al., 2012) along with TTX significantly inhibited both
the frequency (0.21  0.05 Hz, n 
 8) and the amplitude of
rhythmic activity of DAneurons in wild-typemice (Fig. 3C, I,N).
In contrast, the activity ofDAneurons inTRPC1/micewas not
affected, and no decrease in the frequency (0.38 0.04Hz, n
 8)
or amplitude of the rhythmic activity was observed by the addi-
tion of Tg alongwith TTX (Fig. 3G, J,N). Application of 2-APB (a
nonspecific TRPC1 blocker) abolished the effect of Tg-mediated
decrease in rhythmic activity in wild-type mice (Fig. 3D,K)
(0.35 0.06 Hz, n
 6) but showed no decrease in the rhythmic
activity in TRPC1/mice (0.40 0.06 Hz, n
 6) (Fig. 3H,L).
These results further establish that activation of TRPC1 inhibits
spontaneous pacemaking activity in DA neurons.
L-type Ca2 channel activity in the SN region is inhibited
by TRPC1
The results shown above suggest that, in DA neurons, TRPC1
inhibits the autonomous activity driven by L-type VGCCs. To
confirm that functional TRPC1 channels exist in DA neurons, we
stimulated DA neurons with Tg to measure SOCE currents. As
indicated in Figure 4A, B, store depletion induced an inward
TRPC1-like current inWTDA neurons, and the current proper-
ties were similar as previously reported (Liu et al., 2003; Selvaraj
et al., 2012). The addition of 2-APB or knockdown of TRPC1
(TRPC1/) significantly inhibited SOCE currents that were in-
duced by store depletion (Fig. 4A–C), suggesting that TRPC1
channel functions as a putative SOCE channel inDAneurons. To
further confirm the role of TRPC1 in regulating VGCC, we next
recorded the Ca2 currents in the tissue slices from the SN area.
Importantly, the VGCC activity inTRPC1/mice was increased
compared with wild-type control mice. Moreover, store deple-
tion, by the addition of Tg, significantly decreased Ca2 currents
inwild-typemice, whereas no such decrease in the VGCC activity
was observed in TRPC1/ mice (Fig. 4D–G). The addition of
nifedipine was able to block the Ca2 currents in the SN region of
wild-type and TRPC1/ mice (Fig. 4D–F). Similarly, under
physiological conditions, VGCC-mediated Ca2 currents were
also significantly increased in TRPC1/ mice compared with
wild-type (Fig. 4H, I). Moreover, overload of calcium further
increased VGCC-mediated Ca2 currents in TRPC1/ mice
(data not shown). Importantly, no change in the expression of
Cav1.3 or STIM1 or Orai1 was observed in TRPC1
/mice (Fig.
Figure2. Cav1.3 channels contribute to the rhythmic activity of DAneurons. In thewhole-cell configuration, application of 0.5MTTX abolished spiking of GABAneurons inwild-typemice (A,B).
C, Spontaneous APs and application of 0.5M TTX abolished spiking of DA neurons in juvenile mice (P14–P18 d) (D). E, Patterns of AP firing in adult ( p	 28 d) DA neurons from the SN area. F, G,
Application of 0.5MTTXdecreased spiking in adult DAneurons.H, Application of 1MBayK8644 increased spiking. I, The addition of 1Mnifedipine abolished spiking of DAneurons in adultmice.
J, Application of 0.5M TTX along with removing external Ca2 also abolished spiking of DA neurons in adult mice.
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4 J,K), suggesting that alterations inCa2 currents are specifically
dependent on TRPC1 expression.
Recent findings have shown that store depletion induces
STIM1 aggregation and increases STIM1 interaction with
TRPC1, thus activating TRPC1 channels (Huang et al., 2006) that
could suppress L-type Ca2 channel currents. These findings led
us to test whether the TRPC1-STIM1 complex interacts with
Cav1.3. Application of 1 M Tg showed an increase in the pull-
down of Cav1.3 by STIM1 in wild-type mice compared with un-
stimulated conditions (Fig. 5A). However, in TRPC1/ mice,
the store-dependent increase in the STIM1-Cav1.3 association
was abolished, suggesting that STIM1 interaction with Cav1.3 is
Figure 3. TRPC1 inhibits the rhythmic activity of DA neurons in the SN region. In the whole-cell configuration, patterns of AP firing of adult DA neurons ( p	 28 d) in wild-type mice (A) and
TRPC1/mice (E).B, F, AP firing upon application of 0.5M TTX in bothwild-type and TRPC1/ slices. C,G, Rhythmic activity in SN slices that were incubatedwith 1M Tg TTX in wild-type
and TRPC1/mice, receptively.D,H, Rhythmic activity in SN slices that were incubatedwith 1M Tg TTX 50M APB inwild-type and TRPC1/mice, receptively. I–L, Pooled time course
of AP firing frequency under various conditions in WT and TRPC1/ mice (n
 9). M, N, The frequencies and normalized amplitude under these conditions. *Significantly different values
( p 0.05) (n
 9).
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dependent on TRPC1 expression. To establish the importance of
TRPC1 in DA neurons, we next investigated the presence of DA
neurons in the SN area by evaluating the TH expression in
wild-type and TRPC1/mice from the mid region (rostral to
caudal). Interestingly, TH-positive neurons showed that DA
neurons in the SN region were significantly decreased in
TRPC1/ mice compared with the wild-type mice. In con-
trast, DA neurons present in the VTA region showed no such
Figure4. TRPC1modulates Cav1.3 activity in SN area ofmice.A, Representative trace showing store dependent (upon addition of 1M Tg Ca
2 entry at70mVholding potential) that induced
aTRPC1-like current inDAneuronsofWTmicebutwasabolished in the TRPC1/mice.Application50M2-APBalso significantly inhibited the currents inwild-typemice.B, I–V curvesunder these
conditions. C, Maximumcurrent (at70mVholding potential) inwild-typewith andwithout 2-APB and in TRPC1/mice (n
 11).D, Representative trace showed that calcium currents evoked
in DA neurons from SN area using a step protocol from 60 to 10 mV in the whole-cell configuration in wild-type mice. E, Representative I–V relations under these conditions (n 
 8).
F, Representative trace showed that Ca2 currents evoked inDAneurons fromSNarea in TRPC1/mice.G, The average (10–12 recordings) currents under various conditions (n
10). *p0.05.
H, A train of three APs induced Ca2 currents in WT and TRPC1/mice (n
 5). *p 0.05. I, Western blots of lysates from SN tissues from control and TRPC1/mice. Antibodies used are
indicated in the figure. Densitometry for normalized Cav1.3 relative to-actin bar graph is to show quantitation from at least three independent experiments. Data are mean SEM from three
independent experiments. *p 0.05.
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decrease in TH staining, indicating that loss of TRPC1 renders
SN region DA neurons more vulnerable (Fig. 5B–D). Consis-
tent with these results, PD samples also showed a decrease in
TH and TRPC1 expression without any change in STIM1 and
TRPC3 expression, whereas an increase in Cav1.3 channels was
observed (Fig. 5E,F ). Collectively, these results indicate that
inhibition of VGCC channels by TRPC1 (providing the scaf-
fold to allow STIM1-mediated inhibition) may be the check-
point responsible for protecting DA neurons in the SN region
and loss of TRPC1.
TRPC1-STIM1 complex regulates Cav1.3 function
To further confirm the role of TRPC1 and STIM1 in regulating
VGCC, we used differentiated SH-SY5Y neuroblastoma cells and
evaluated SOCE activity in these cells. Importantly, store deple-
tion (addition of Tg) showed a robust increase in the Ca2 entry
(SOCE) in control cells, which was significantly decreased in
TRPC1-silenced cells (Fig. 6A). TRPC1 protein levels were also
decreased in TRPC1-silenced cells (Fig. 6A). In addition, whole-
cell recordings for VGCC were also performed, and knockdown
of TRPC1 significantly facilitated VGCC activity without chang-
ing the I–V relationship (Fig. 6B,C,K). Importantly, no change in
the inactivation of the VGCC currents was observed in TRPC1
silenced cells (Fig. 6D). Both the pore-forming 1-subunits of
VGCC, Cav1.2, and Cav1.3 are expressed in DA cells (Sinnegger-
Brauns et al., 2009; Kang et al., 2012) and are inhibited by
nifedipine. To distinguish which channel is mediated by the
pharmacological effect of nifedipine in DA cells, we silenced
Cav1.3 in differentiated SH-SY5Y cells. Notably, siCav1.3 de-
creased VGCC activity and abolished the effect of siTRPC1 on
Ca2 currents, indicating that TRPC1 modulates Cav1.3 activity
(Fig. 6E,F). Similar resultswere also obtainedwith STIM1 silenc-
ing where decreased expression of STIM1 not only decreased
STIM1 levels but also potentiated Cav1.3 activity (Fig. 6G,H). In
addition, STIM1 silencing decreased store-mediated Ca2 entry
in SH-SY5Y cells, whereas restoration of STIM1 expression in
STIM1 silenced cells (rescue) was able to restore STIM1 expres-
sion as well as store-mediated Ca2 entry (Fig. 6 I, J).
To establish the mechanism as to how TRPC1 modulates
VGCC, we performed single-channel analysis in control and
stimulated conditions (store depletion). Importantly, an increase
in the single-channel activity of the L-type Ca2 currents was
observed, which was inhibited by the addition of nifedipine (Fig.
7A,B). Importantly, store depletion also showed a decrease in the
single-channel activity of the L-type Ca2 currents (Fig. 7A,C).
Finally, silencing of Cav1.3 in these cells confirmed that these
currents are mediated via the L-type Ca2 channels, and store
depletion along with silencing does not further decrease these
currents (Fig. 7D,E). As TRPC1 is active upon store depletion,
these results suggest that activation of TRPC1 increases STIM1
interaction with VGCC to decrease VGCC activity. To further
confirm these results, we tested whether these proteins physically
interact in SH-SY5Y cells. Consistent with the in vivo studies,
immunoprecipitation using STIM1 antibodies resulted in coim-
Figure 5. TRPC1 provide STIM1 scaffold that protects TH-positive neurons in SN region. A, Western blots of coimmunoprecipitates of SN tissues using STIM1 antibody under control (CTRL) and
stimulated (store depletion, Tg) conditions. Bar graph represents densitometry for fold change in Cav1.3 pulldown to show quantitation from at least three independent experiments.
B, Representative DAB images of brain sections showing full SN region stainedwith TH antibody fromwild-type and TRPC1/mice. C, Bar graph represents stereology of TH staining from rostral
to the caudal region. Data are mean SE. *Significantly different values ( p 0.05). n
 4. D, Immunostaining of TH cells in SN and VTA region obtained from wild-type and TRPC1/mice.
E, Western blots of lysates from SN tissues from control and PD samples. Antibodies used are labeled in the figure. F, Densitometric quantitation for normalized TRPC1 or Cav1.3 relative to TH
expression. Data are mean SEM from three independent experiments. *p 0.05.
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munoprecipitation of Cav1.3 and TRPC1 (Fig. 7F). Importantly,
store depletion (Tg) showed a significant increase in Cav1.3-
TRPC1-STIM1 interaction (Fig. 7F). Similar results were also
obtained using Cav1.3 antibodies, which showed that Cav1.3 in-
teracts with STIM1 and TRPC1 and the association between
Cav1.3-TRPC1-STIM1 was again increased upon Tg treatment
(Fig. 7F). We further tested the importance of this association,
and cell viability assays were performed. Importantly, TRPC1 or
Figure 6. Cav1.3 channel activity in SH-SY5Y cells is regulated via TRPC1-STIM1. Representative Ca
2 traces in differentiated SH-SY5Y cells showed that silencing of STIM1 significantly inhibited
Ca2 influx thatwas induced upon store depletion ( 1M Tg) (A). STIM1 or TRPC1 silencing increases L-type calcium currents (B andG, respectively). The average (8–10 recordings) I–V relations
under these conditions are shown in C andH, respectively (n
 9). *p 0.05. Mean steady-state inactivation curves were obtained for L-type current in control and siTRPC1 (D). n
 5. Silencing
of Cav1.3 (E, F ) abolished the effect of siTRPRC1 on the L-type calcium current. Insets,Western blots from lysates of differentiated SH-SY5Y cells showing decreased expression of TRPC1, Cav1.3, and
STIM1 (aswell as overexpressionof STIM1 in siSTIM1 cells, rescue) using respective siRNAs. Overexpressionof full-length STIM1 in siSTIM1-expressing cells (rescue) showedan increase in Ca2 influx
(I, J ). K, Average histogram for current density in various conditions. *p 0.05.
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Figure 7. TRPC1 affect Cav1.3 channels in SH-SY5Y cells. Single-channel recording (from individual differentiated 10–12 SH-SY5Y cells in each condition) using step protocol from40mV to 10
mV in control (A), nifedipine (1M) (B), Tg-treated (1M) cells (C), and siCav1.3 cells (D, E). Variance histograms were generated with Gaussian fits and are shown at the bottom of the traces.
F, Western blots of coimmunoprecipitates of SH-SY5Y cells using Cav1.3 or STIM1 antibodies in control (CTRL) or stimulated (Tg) conditions. Antibodies used for Western blots are labeled in the
figure. Quantification of the data from3 to 5 independent experiments is shown. *Significantly different values ( p0.05).n
8.G, Cell viability under various conditions in SH-SY5Y cells is shown.
*Significantly different from untreated cells ( p 0.05). n
 4.
Sun et al. • TRPC1 Inhibit Cav1.3 to Protect DA Neurons J. Neurosci., March 22, 2017 • 37(12):3364–3377 • 3373
STIM1 silencing significantly decreased cell viability thatwas par-
tially rescued by the addition of nifedipine (Fig. 7G). Further-
more, the rescue of STIM1 (overexpressing STIM1 after STIM1
silencing) was able to restore cell viability (Fig. 7G). Overall, these
results suggest that TRPC1 decreases L-type Ca2 currents by
providing STIM1 scaffold, and loss of TRPC1-mediated modu-
lation of Cav1.3 channels could lead to DA cell death.
TRPC1 regulates Cav1.3 function in neurotoxin model of PD
Neurotoxins (such asMPTP/MPP) thatmimic Parkinson’s dis-
ease have been shown to selectively affect the survival of DA
neurons. Our previous studies have shown thatMPP treatment
specifically decreased TRPC1 activity (Selvaraj et al., 2012), but
the mechanism as for why these cells die was not clear. Thus, we
performed electrophysiological recordings on SH-SY5Y cells
with and without MPP treatment. As indicated in Figure 5,
MPP-treated cells showed an increase in Ca2 currents (Fig.
8A,B). Also, the Tg-mediated inhibition of Ca2 currents was
abolished uponMPP treatment (Fig. 8A,B). Importantly, over-
expression of TRPC1 inhibited the MPP-induced increase in
L-type calcium currents, suggesting that restoration of TRPC1
expression is essential for the inhibition of L-type calcium cur-
rents (Fig. 8A). Notably, siCav1.3 also abolished the effects of
MPP and Tg on Ca2 currents, which further suggest that
Cav1.3 is involved in MPP
-facilitated Ca2 currents (Fig.
8C,D). MPP treatment also showed a decrease in TRPC1 ex-
pression without altering STIM1 levels, suggesting a prominent
role of TRPC1 in the regulation of Cav1.3 currents (Fig. 8E,F).
Consistent with these results, the association between Cav1.3-
TRPC1-STIM1 was decreased in MPP-treated cells (Fig.
8G,H). To further study the role of Cav1.3 in neurotoxin models
of PD as well as establish the consequence of Cav1.3-TRPC1 in-
teractions in PD, we investigated proteins that induce cell death
in the MPP/MPTP model. Here we found that pretreatment
with nifedipine or siCav1.3 significantly decreased caspase 3 acti-
vations (as observed by cleaved active caspase) and Bak protein
levels in the MPPmodel (Fig. 8I). Furthermore, similar results
were attained in the MPTP vivo model where subsequent in-
creases in caspase 3, Bak, and Bid apoptotic proteins was ob-
served. Interestingly, overexpression of TRPC1 in the SN region
inhibited MPTP-induced increases in apoptotic proteins (Fig.
8J). Finally, pretreatment with nifedipine, siCav1.3, or overex-
pression of TRPC1 partially preventedMPP-induced cell death
(Fig. 8K). Together, these data suggest that TRPC1 facilitates
STIM1-Cav1.3 interactions to suppress Cav1.3 activity that inhib-
its caspase3 activation and decreases apoptosis, thereby protect-
ing DA cells against neurotoxin-mediated insults that lead to PD.
Discussion
Although the mechanisms responsible for the preferential loss of
DA neurons in PD have been debated for decades, loss of Ca2
homeostasis could be the most important. Ca2 is crucial for a
broad range of neuronal functions, and regulation of intracellular
Ca2 concentration represents amajor determinant that controls
neuronal growth and survival, gene regulation, neuronal excit-
ability, synaptic transmission, and plasticity (Berridge et al., 2000;
Sippy et al., 2003; Burgoyne, 2007). Pathological neuronal insults
evoke an unwanted rise in cytosolic Ca2 levels, leading to Ca2
overload that causes toxicity and neuronal cell death (Stout et al.,
1998; Berridge et al., 2000). VGCCs are multimeric proteins that
are essential for the Ca2 influx in neuronal cells. Although
several VGCC subunits have been identified, the pore-form-
ing 1-subunit is the principal determinant for gating and phar-
macology. DA neurons have one of the two 1-subunits, Cav1.2
or Cav1.3, thatmodulate Ca
2 influx necessary for their function.
In PD, a change has been shown in the ratio of Cav1.2 versus
Cav1.3 that favors a greater utilization of Cav1.3 channels, which
contributes to the function of DA SN neurons and also seems to
render neurons susceptible to excitotoxicity and/or oxidative
stress (Henchcliffe and Beal, 2008; Goldberg et al., 2012).
The role of the L-type Ca2 channels in pacemaker activity is
still controversial. Previous studies indicate that, in adult DA
neurons, the pacemaking activity involves VGCC channels (es-
pecially Cav1.3) (Nedergaard et al., 1993; Mercuri et al., 1994;
Chan et al., 2007; Puopolo et al., 2007; Guzman et al., 2009;
Putzier et al., 2009; Drion et al., 2011). In contrast, other studies
report the activity of VGCC is not necessary for firing but does
contribute to slow oscillatory potentials, which will trigger Na
spikes (Guzman et al., 2009; Dragicevic et al., 2014), suggesting
that for the oscillatory phenomenon underlying the pacemaking
activity involves amix of calciumand sodiumchannels. Although
these studies indicate that Cav1.3 contributes to pacemaking ac-
tivity, the mechanism of regulation and whether VGCC is essen-
tial for SNDA neurons pacemaker activity remains questionable.
Importantly, Cav1.3 channels contribute to their progressive loss
as observed in PD pathology (Surmeier et al., 2012; Dragicevic et
al., 2015). Furthermore, blood–brain barrier-permeable VGCC
blockers (e.g., isradipine) protect highly vulnerable DA SN neu-
rons fromdegeneration in PD and chronic rodentmodels (Ritz et
al., 2010; Ilijic et al., 2011), presumably by reducing Ca2 over-
load and mitochondrial stress during pacemaking (Guzman et
al., 2010; Dragicevic et al., 2015). One possibility for these dis-
crepancies could be that other Cav1.3 activity-modulating pro-
teins/channels could be expressed differently. In addition, Cav1.3
might cooperate with sodium channels to generate pacemaking
with a degree of cooperation that is variable (Drion et al., 2011).
Thus, although Cav1.3 contributes to the pacemaking activity in
DA neurons, it comes with a high metabolic cost. Cytosolic Ca2
levels are tightly controlled, and ATP is needed to sequester Ca2
to inhibit abnormal activation of cells. Thus, dependence on
Ca2 for the pacemaking activity could be detrimental for DA
neurons. Our results show that, in normal conditions, Cav1.3-
mediated pacemaking activity is inhibited by TRPC1 thereby
protecting DA neurons.
In addition to VGCC, Ca2 release from intracellular ER/SR
stores activates Ca2 influx via the SOCE mechanism. The
VGCC-mediated Ca2 entry differs from SOCE as VGCCs are
activated by depolarization in response to APs, whereas SOCE is
activated in response to ER/SR Ca2-store depletion. Notably,
both SOCE and VGCC channels are expressed in neurons
(Stru¨bing et al., 2001; Selvaraj et al., 2010; Sun et al., 2014); how-
ever, the function of SOCE channels in neuronal cells is not well
defined. Members of the TRPC and Orai family have been sug-
gested as Ca2 entry channels that regulate SOCE. Additionally,
STIM1 has shown to link ER Ca2 store depletion and SOCE
activation (Pani et al., 2008, 2012). Upon store depletion, STIM1
aggregates at ER-PM junctions that facilitate its interaction with
TRPC1/Orai1 channels, thereby activating SOCE. Importantly,
in PD and neurotoxin-treated samples, only TRPC1 expression
was altered, whereas no change inOrai1 or STIM1 expressionwas
observed, suggesting that TRPC1 could have a role in PD. Recent
studies have also shown that STIM1 strongly suppresses VGCCs
(Park et al., 2010; Wang et al., 2010; Harraz and Altier, 2014);
however, nothing is known as to whether STIM1 regulates Cav1.3
channels and, if so, what mediates this interaction or what is the
physiological function of this inhibition.Our results show that, in
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DA neurons, STIM1 suppressed Cav1.3 channels by interacting
with Cav1.3; more importantly, this association was dependent on
TRPC1 expression as TRPC1 knock-out mice or TRPC1 silencing
showed a significant decrease in store-dependent Cav1.3-STIM1 in-
teraction.Moreover, storedepletion increasedTRPC1-STIM1inter-
action and facilitated its association with Cav1.3 channels, further
suggesting that TRPC1 is essential for providing the scaffold neces-
sary for the inhibition of Cav1.3 channels.
A novel aspect of this study is the documentation of the sig-
nificance of TRPC1 in regulating L-type Ca2 channel, especially
Cav1.3 function. Our findings reveal that TRPC1 acutely reduced
Cav1.3 currents, which lead to decreasedCa
2 entry that could be
essential for the inhibition of oxidative stress, thereby increasing
the survival of DA neurons. One reason that DA neurons are
more vulnerable is the abnormal activation of Cav1.3 channels,
which facilitates sustained elevations in cytosolic Ca2 concen-
Figure 8. TRPC1 regulates Cav1.3 function in neurotoxin PDmodel. A, Representative trace showed that calcium currents were evoked in differentiated SH-SY5Y cells with a step protocol from
60 to 10mVunder various conditions. Cells treatedwithMPP facilitated calcium current, but overexpression of TRPC1 abolished this effect.B, I–V curves. E, F,Western blots of lysates in control
andMPP-treated SH-SY5Y cells (500M, 24h).C,D, Individual traces of L-type calciumcurrents in Cav1.3 silenced cellswith andwithoutMPP
 and/or Tg treatment.G,H, Coimmunoprecipitates
of SH-SY5Y cells using Cav1.3 and STIM1 antibodies under various conditions. I,Western blots of lysates fromdifferentiated SH-SY5Y cells using cleaved caspase3, Bak, and-actin antibodies under
various conditions. J, Western blots of lysates frommice SN region using cleaved caspase3, Bak, Bid, and-actin antibodies under various conditions. For MPTP treatment, mice receivedMPTP-HCl
25 mg/kg (i.p. for 5 consecutive days at 24 h intervals). Densitometric quantitation for normalized relative to-actin is shown below the blots. Values are mean SEM from three independent
experiments. *p 0.05. K, Cell viability under various conditions in SH-SY5Y cells. *Significantly different values from untreated cells ( p 0.05). n
 8.
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tration (Wilson and Callaway, 2000). Increased cytosolic Ca2
could induce mitochondrial dysfunction, and the resulting in-
crease in reactive oxygen species could further advance these DA
neurons toward degeneration (Dauer and Przedborski, 2003;
Abou-Sleiman et al., 2006; Selvaraj et al., 2010; Sun et al., 2014).
In addition to susceptibility to mitochondrial toxins, a decrease
in ER Ca2 levels is also known to induce ER stress, which could
activate the cell death cascades, as observed in PD (Nguyen et al.,
2002; Holtz and O’Malley, 2003; Yoshida et al., 2006; Sun et al.,
2014). Importantly, restoration of ER Ca2 stores via TRPC1
activation could protect DA cells against such conditions. Thus,
activation of TRPC1 could suppress Cav1.3 channels, thus reduc-
ingmitochondrial dysfunction and alleviate ER stress to improve
DA neurons survival.
Although mechanistic insights regarding how STIM1/TRPC1
may inhibit VGCC needs further investigation, elucidating the
relationship between SOCE and VGCC channels in DA neurons
could provide insights into themolecular cascade critical for neu-
ronal loss. Herein, our results offer a novel mechanism where
TRPC1 regulates Cav1.3 channel activity, without altering its in-
activation. TRPC1 knock-out mice showed an increase in Cav1.3
channel activation and loss of TH-positive neurons, which could
be due to increase in the rhythmic activity as nifedipine protected
these DA neurons. In addition, TRPC1-mediated inhibition of
Cav1.3 channels was dependent on STIM1 as STIM1 silencing
decreased SOCE and increased Cav1.3 activity and loss of TRPC1
abolished STIM1-Cav1.3 interaction. Moreover, neurotoxins
that mimic PD increased Cav1.3 channel activity, and only
TRPC1 expression was affected, suggesting that TRPC1 plays an
important role in neurotoxin-mediated cell death. Silencing
Cav1.3 or overexpressing TRPC1 both decreased caspase3 and
inhibited MPP-induced cell death. Thus, it could be suggested
that TRPC1 expression facilitates STIM1-Cav1.3 interactions and
is essential for the survival of DA neurons. Although TRPC1 is
expressed in most neuronal cells, its loss is only observed in DA
neurons in the SN region. Importantly, Cav1.3 channels are
found at a significantly higher density in DA neurons in the SN
region than in the VTA region. Thus, TRPC1-mediated inhibi-
tion of Cav1.3 channels is specific as it protects DA neurons by
reducing the rhythmic activity in the SN region. However, loss of
TRPC1 due to the presence of toxins or other insults could ab-
normally activate Cav1.3 channels that would render these
neurons vulnerable. In essence, activity-related cellular Ca2
load, mitochondrial dysfunction, as well as oxidative and meta-
bolic stress are particularly important trigger factors for PD
(Dragicevic et al., 2015). Moreover, epidemiological studies have
shown an association between the use of dihydropyridines
(VGCC inhibitors) and decrease the risk for PD (Ritz et al., 2010;
Marras et al., 2012), which further suggests that TRPC1 activators
could also be a candidate for treating PD patients. Of additional
importance is that TRPC1 is also essential for inhibiting ER stress;
thus, TRPC1 activation could not only inhibit Cav1.3-induced
oxidative stress but also inhibit ER stress that together would
protect DA neurons from the majority of stressors known to
cause PD.
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